Enterprise League logo
Promis Diagnostics Logo

Promis Diagnostics

Irvine, United States (US) · Health and Medical

Do you work at Promis Diagnostics?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#molecular

#cancer

#biotechnology

#genetics

#genomics

Promis Diagnostics is an Irvine, California-based biotechnology company specializing in early cancer detection.We develop and commercialize innovative, noninvasive diagnostic solutions leveraging our patented LTE-qMSP technology, which utilizes PCR and methylated DNA biomarkers to detect colorectal, bladder, and lung cancer with high sensitivity and specificity.Our mission is to empower patients with actionable insights and affordable screening options, ultimately improving health outcomes.

Overview

Promis Diagnostics is an Irvine, California-based biotechnology company specializing in early cancer detection.

We develop and commercialize innovative, noninvasive diagnostic solutions leveraging our patented LTE-qMSP technology, which utilizes PCR and methylated DNA biomarkers to detect colorectal, bladder, and lung cancer with high sensitivity and specificity.

Our mission is to empower patients with actionable insights and affordable screening options, ultimately improving health outcomes. We are dedicated to providing accurate, accessible, and fast testing solutions for early cancer diagnosis, contributing to a healthier future for all.

Founded in 2019, Promis Diagnostics is committed to advancing cancer screening through rigorous research and development, evidenced by our publications and recognition within leading medical guidelines.
Visit Official Website

Most teams do this before shortlisting


Contact Details

+1949-687-1212
info@promisdx.com

Irvine, United States (US), 1 Post

Founded

2019

Company Type

Private Limited Company

Employees

10-20

Categories

Biopharma
Life Science
Biotechnology

Keywords

#molecular

#cancer

#biotechnology

#genetics

#genomics

Awards

• 2026 OpenSee all

Products

Default Product Image
EarlyTect BCD
Biotechnology

EarlyTect BCD is a urine-based test designed for the early detection of bladder cancer. It utilizes our patented LTE-qMSP technology to identify methylated DNA biomarkers indicative of bladder cancer, offering a convenient and accurate screening option.

N/A


Services

Default Product Image
Urinalysis
Biotechnology

Our urinalysis service provides a comprehensive analysis of urine samples, complementing EarlyTect BCD and offering a broader assessment of potential health concerns.

N/A

Companies teams usually look at after Promis Diagnostics

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.